BioNTech SE Officer and Director Holdings Update

This filing details the power of attorney granted by Sierk Poetting, Chief Operating Officer of BioNTech SE, to specific individuals for handling SEC reporting obligations. It outlines the authority granted to these attorneys-in-fact to submit applications for SEC access, take necessary actions for the undersigned, execute Section 16 filings, Forms 144, and Schedules 13D/13G, and obtain information regarding Company securities. The power of attorney also covers the execution and delivery of amendments to these filings and seeking information from third parties. The document confirms that the attorneys-in-fact are not assuming the undersigned's reporting responsibilities. The filing also includes details of Poetting's direct and indirect holdings in BioNTech SE, including ordinary shares, options, and phantom options with various exercise prices and expiration dates. The power of attorney is effective until Poetting is no longer required to file such information or until earlier revoked.